ACAD Operating Income Growth
Acadia Pharmaceuticals Inc · Operating Income Growth
ACAD Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-63.53%period ending
ACAD TTM Operating Income YoY % (-10.64% → -63.53%)
Year-over-year change
High-resolution chart · PNG
ACAD operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -63.5291% | |
| -65.5539% | |
| -54.5868% | |
| 114.6594% | |
| 937.9619% | |
| 5,222.6609% | |
| 414.5232% | |
| 172.6977% | |
| 117.8975% | |
| 97.2071% | |
| 67.1823% | |
| 30.5162% | |
| 38.3056% | |
| 24.2377% | |
| -31.1883% | |
| -15.1578% | |
| 21.5969% | |
| 17.8743% | |
| 40.5278% | |
| 30.0479% | |
| -11.9811% | |
| -6.2059% | |
| -16.2408% | |
| -7.1486% | |
| 13.8785% | |
| 11.3584% | |
| 0.3633% | |
| -2.8951% | |
| -7.0736% | |
| -7.9692% | |
| 15.7092% | |
| 17.0998% | |
| 17.102% | |
| 16.6322% | |
| -7.6041% | |
| -25.6645% | |
| -48.9108% | |
| -78.6114% | |
| -65.7321% | |
| -62.7004% | |
| -54.7538% | |
| -50.5059% | |
| -76.5655% | |
| -92.0926% | |
| -113.2246% | |
| -131.2318% | |
| -143.4458% | |
| -133.1917% | |
| -155.2491% | |
| -140.5975% | |
| -83.3573% | |
| -70.017% | |
| -11.2385% | |
| 10.3479% | |
| 8.6032% | |
| -267.2073% | |
| -277.3589% | |
| -257.6511% | |
| -251.3879% | |
| 150.9719% | |
| 145.6219% | |
| 141.1487% | |
| 133.1984% | |
| 55.389% | |
| 53.2124% | |
| 44.5102% | |
| 32.9207% | |
| 29.4751% | |
| 21.3183% | |
| 4.6288% | |
| -8.1878% | |
| -25.7031% | |
| -42.0692% | |
| -29.073% | |
| -27.7272% | |
| -24.4489% | |
| -12.1967% | |
| -30.6684% | |
| -36.9954% | |
| -41.893% | |
| -78.2631% | |
| -57.5049% | |
| -37.2141% | |
| 14.1158% | |
| 12.3534% | |
| 4.8634% | |
| -10.6413% |